1991
DOI: 10.1016/s0272-6386(12)81131-0
|View full text |Cite
|
Sign up to set email alerts
|

Utility of Immunofluorescence of Urine Sediment for Identifying Patients With Renal Disease Due to Monoclonal Gammopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…More sophisticated urine testing has confirmed that LCs can be seen in the urine. Immunofluorescence (IF) staining (anti-sera to LC immunoglobulins) of the urine sediment was used to identify monoclonal LCs in patients with kidney disease and various monoclonal gammopathies [ 6 ]. Urinary casts and other various shaped particles were demonstrated in the urine of 20 out of 27 patients with monoclonal disease and 0 out of 25 patients with non-monoclonal kidney disease.…”
Section: Myeloma Light Chain Crystalline Nephropathymentioning
confidence: 99%
“…More sophisticated urine testing has confirmed that LCs can be seen in the urine. Immunofluorescence (IF) staining (anti-sera to LC immunoglobulins) of the urine sediment was used to identify monoclonal LCs in patients with kidney disease and various monoclonal gammopathies [ 6 ]. Urinary casts and other various shaped particles were demonstrated in the urine of 20 out of 27 patients with monoclonal disease and 0 out of 25 patients with non-monoclonal kidney disease.…”
Section: Myeloma Light Chain Crystalline Nephropathymentioning
confidence: 99%